Category: New Treatments

Check Out the January 2018 Edition of our newsletter

Want to know more about what we are doing at ALCF? Read our most recent newsletter to see our 2017 year in review, meet our new partner, IASLC, learn how you can get involved in our immunotherapy study, participate in a fun new way to raise funds through social sharing called the Your Cancer Game… Read More

Posted by ALCF Staff on February 1st, 2018

We Challenge You! Join ALCF and the Your Cancer Game Plan Challenge!

We’re excited to announce that we’ve joined Merck on the Your Cancer Game Plan Challenge, a social sharing program that will help us raise funds and continue our support of lung cancer patients, caregivers, healthcare providers and others. And we’d like to challenge you to join our team. During the month of February, Merck will… Read More

Posted by ALCF Staff on January 31st, 2018

With healthcare reform, Congress can’t forget what works

Laurie Fenton Ambrose and Bonnie J. Addario wrote and Op Ed for “The Hill” about views on healthcare reform. The article states that “healthcare cannot break down into partisan politics…It impacts everyone regardless of politics.” They stress the importance of coverage for people with pre-existing conditions, early detection and access to new medications. Click here… Read More

Posted by ALCF Staff on September 22nd, 2017

Patient value: Perspectives from the advocacy community

The paradigm of decision making for healthcare must change. It is imperative that patients are part of the equation. According to this article, co-authored by Bonnie J. Addario, “There is substantial evidence to show that patient-centred care improves patient satisfaction, adherence to medications, improved chronic disease control, quality of care and health outcomes while reducing… Read More

Posted by ALCF Staff on September 20th, 2017

Patient Advocacy Strategies Evolve as Genomic Advances Change Understanding of Cancer

The ROS1ders, are throwing their energy behind creating preclinical mouse models and cells lines that will inform drug development efforts and improve understanding… Read More

Posted by ALCF Staff on September 8th, 2017

Patient Engagement is Mandatory

Bonnie and Daryl Pritchard, PhD, from the Personalized Medicine Coalition talk about the importance of personalized medicine and how a registry that can serve as a repository for data on patients with lung cancer— is a means to empower patients and assist care providers to deliver personalized medicine in a patient-centered manner. Read the full… Read More

Posted by ALCF Staff on August 9th, 2017

Lung Cancer Updates from 2017 ASCO Annual Meeting

Each year in early June the American Society for Clinical Oncology holds its Annual Meeting (called simply “ASCO”) in Chicago. The theme for the 2017 meeting was “Making a Difference in Cancer Care WITH YOU.” Over 39,000 cancer researchers, clinicians, patient advocates, and industry representatives from around the world gathered to discuss the latest scientific… Read More

Posted by Janet Freeman-Daily on July 26th, 2017

How Corporations Really Know What’s Good for the Patient

Richard Goodfellow of CEO of biotech Scancell Talks about how patient advocacy groups are central to understanding patient needs. He emphasizes that working with advocacy groups are an innovative and productive way of ensuring patients are at the forefront of everything they do. Click here to read the full commentary

Posted by Richard Goodfellow on July 26th, 2017

Read Bonnie’s blog post about the excitement in Lung Research from ASCO

This year at ASCO, lung cancer was all the buzz. Lung cancer is quickly becoming the lead in the discovery of cancer mutations and other drivers relative to advancing therapies and survival. There are now many possibilities in the future of all cancers beginning with chronic management and onto future cures. Read Bonnie’s blog about… Read More

Posted by ALCF Staff on June 20th, 2017

ALCMI and Biocept Announce a Landmark Liquid Biopsy Clinical Trial

The Addario Lung Cancer Medical Institute (ALCMI) and Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announce a clinical collaboration and initiation of the landmark ALCMI-009 liquid biopsy clinical trial, which was developed and will be conducted by ALCMI and its consortium of… Read More

Posted by ALCF Staff on May 10th, 2017